No One Missed: The Vital Role of Comprehensive Biomarker Testing in Non-Small Cell Lung Cancer
According to the American Cancer Society’s 2021 report, lung cancer accounted for almost half of the overall decline in cancer mortality from 2014 to 2018.* This is largely due to advances in new lung cancer therapies, particularly those targeted to specific biomarkers.**
During this panel discussion, we explore the vital role of comprehensive biomarker testing in helping inform treatment decisions for people living with non-small cell lung cancer (NSCLC). The panel features medical experts with both clinic and research experience to dispel the mystery of comprehensive biomarker testing for NSCLC patients. In addition, you’ll hear from a patient-caregiver duo about their personal experience with biomarker testing and how it helped change their lung cancer journey.
Topics addressed include:
•What is comprehensive biomarker testing?
•How might comprehensive biomarker testing impact my NSCLC treatment plan?
•New resources to begin a discussion with your doctor.
Meet the panelists:
•Tabitha Paccione, lung cancer patient and advocate
•Tony Paccione, lung cancer caregiver and Tabitha’s husband
•Ray Osarogiagbon, M.D., Multidisciplinary Thoracic Oncology Program Director, Baptist Cancer Center
•Jorge Gomez, M.D., Medical Oncologist, Thoracic Oncology Program, Mount Sinai
The discussion is moderated by Andrea Ferris, President and Chief Executive Officer of LUNGevity Foundation.
No One Missed is a community-led campaign driven by LUNGevity Foundation and comprised of patient advocacy, pharmaceutical and biotechnology organizations. The campaign’s mission is to build public awareness of comprehensive biomarker testing as a critical part of an NSCLC diagnosis and empower NSCLC patients to discuss comprehensive biomarker testing with their healthcare team. Learn more at NoOneMissed.org.
*American Cancer Society. Facts & Figures 2021 Reports Another Record-Breaking 1-Year Drop in Cancer Deaths. Atlanta: American Cancer Society; 2021. https://www.cancer.org/latest......./facts-and-figures
**Howlader N, Forjaz G, Mooradian MJ, et al. The Effect of Advances in Lung-Cancer Treatment on Population Mortality. N Engl J Med. 2020;383:640-649. https://www.nejm.org/doi/10.1056/NEJMoa1916623
-
Category
No comments found